Ledger.Open graph →
SEC Form D · Amendment · filed November 15, 2023

Cognito Therapeutics Ltd

Offering
$126.2M
Sold
$108.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Richard Kuntz · Cambridge, MADirectorGerald Chan · Cambridge, MADirectorBrent Vaughan · Cambridge, MAExec · DirectorHelen Liang · Cambridge, MADirectorStephen Bruso · Cambridge, MADirectorAndrew Michau · Brooklyn, NYDirectorRichard Kuntz · Cambridge, MADirectorMichael T. Lawless · Boulder, CODirectorJohn Gutierrez · Brooklyn, NYExec · DirectorDavid Tugendhaft · Brooklyn, NYDirectorChun Yi George Bridge Tower Partners GP, LP · Dallas, TXExec · DirectorRoger T. Johnson · Glendale, AZDirectorRichard H. Lewis · Saskatoon, Saskatchewan, CanadaDirectorPer Langoe · Tempe, AZDirectorRoss Pearlman, Md · Madison, MSDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗